dihexa human trials or clinical studies trial status Dihexa shows neurotrophic activity exceeding BDNF in preclinical DIHEXA | Peptide Synthetic dihexa human studies clinical trials

The goal isn't to megadose it's to restore and maintain levels in the high-normal range where your cells have what they need

[DOI] [PMC free article] [PubMed] [Google Scholar] 583

The FDA placed it on a Category 2 do-not-compound list in 2023 over impurity and immune-reaction concerns, so no licensed compounding pharmacy can prepare it either

LL-37 provides antimicrobial defense while simultaneously signaling keratinocyte migration and immune cell activation

If symptoms return, a second injection can be used after at least 1 hour

In one case study, a 5 month old breastfed infant of a vegan mother (who actually received a prenatal vitamin containing 96% of her daily needs of B12 throughout her pregnancy) presented with many of the above symptoms and required a 19 day hospital stay to stabilize